Residual neuromuscular block
Conditions
Interventions
experimental group:routine use of neostigmine
control group:use of neostigmine under neuromuscular monitor
Sponsors
West China Hospital, Sichuan Universtiy
Eligibility
Sex/Gender
All
Age
No minimum to 12 Years
Inclusion criteria
Inclusion criteria: 1. ASA I-II; 2. Hernia repair patients aged 3 months to 12 years old; 3. Use of neuromuscular block agents during operation.
Exclusion criteria
Exclusion criteria: Patients with neuromuscular junction disease, cardiovascular disease, respiratory disease and hepatic disease; Use of any drugs may interfere the funcion of neuromuscular junction within 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the incidence of residual neuromuscular block;the incidence of neostigmine induced muscle paraysis; | — |
Secondary
| Measure | Time frame |
|---|---|
| the time between the end of operation and extuation;the time between the end of operation and patient transferred out of OR;the length of stay in PACU;the incidence of hypoxia during PACU stay;the number of patients need assisted ventilation during PACU stay;adverse events related to the use of neostigmine; | — |
Countries
China
Contacts
Public ContactYunxia Zuo
West China Hospital, Sichuan Universtiy
Outcome results
None listed